Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituentJoseph L Duffy, Thomas A Rano, Nancy J Kevin, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2003
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituentJoseph L Duffy, Brian A Kirk, Nancy J Kevin, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strainsJoseph L Duffy, Nancy J Kevin, Brian A Kirk, et al.Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavirNancy J Kevin, Joseph L Duffy, Brian A Kirk, et al.Antimicrobial Agents and Chemotherapy|October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A proteaseNigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virusZhijian Lu, Subharekha Raghavan, Joann Bohn, et al.Journal of Medicinal Chemistry|September 4, 2009
Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infectionCristina Gardelli, Barbara Attenni, Monica Donghi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccinationAdam C Finnefrock, Aimin Tang, Fengsheng Li, et al.Chemmedchem|July 26, 2017
Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876Casey C McComas, Anandan Palani, Wei Chang, et al.Genomics|August 28, 2007
Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemiaPek Yee Lum, Yudong D He, J Greg Slatter, et al.Pageof 11